---
title: "Equilibrium Inc."
author: "Akshay Gulabrao"
date : "2025 October 23"
bibliography: library.bib
link-citations: true
---
[Home](./index.html)

Equilibrium Inc. currently trades at $1.32 as of 2025/10/23. There main drug is EQ504.

Aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a classical exogenous synthetic ligand of AHR that has significant immunotoxic effects [@chenModulatingAHRFunction2023].